NOS3 and atherosclerosis: Consistent with this hypothesis, we observed that elevated NO production and eNOS function in cultured HUVECs, endothelium and liver by DMY administration were associated with improvement of lipid metabolism and inhibition of hepatic inflammation and atherosclerosis.